Top stories






LifestyleHeineken helped South African fans beat World Cup beer prices with the return of Bar De Change
MSL Group 13 Jul 2026
More news














Yongli Zhang and third-year graduate student Junyi Jiao were able to manipulate folds of gp41 protein, which is the target of AIDs drug enfuvirtide. Patients treated with enfuvirtide gradually develop drug resistance, due to gene mutation of gp41.
The researchers found that the drug inhibits the folding of the protein but that ability is lost in patients already treated with enfuvirtide. Their research is described the week of 18 May 2015 in the journal Proceedings of the National Academy of Sciences.
Source: Yale University